A Phase I/II Study of Temsirolimus, Paclitaxel, and Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
[Protocol 09-131] |
Fury, Matthew, MD, PhD |
A Phase II Study of Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
[Protocol 11-005] |
Lee, Nancy, MD |
A Phase II Study of Pralatrexate with Vitamin B12 and Folic Acid for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer
[Protocol 10-112] |
Ho, Alan, MD, PhD |
A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma
[Protocol 09-083] |
Fury, Matthew, MD, PhD |
A Phase IIB Study of Pioglitazone for Oral Precancers
[Protocol 09-163] |
Boyle, Jay, MD |
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] |
Lee, Nancy, MD |
A Pilot Study to Assess the Pharmacodynamic Effects of Ribavirin in Patients with Operable Tonsil Squamous Cell Carcinoma
[Protocol 10-218] |
Fury, Matthew, MD, PhD |
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
[Protocol 07-098] |
Pusic, Andrea, MD, MHS |
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
[Protocol 04-070] |
Lee, Nancy, MD |
Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Tongue Function after Treatment for Tongue Cancer
[Protocol 02-093] |
Kraus, Dennis, MD |
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
[Protocol 07-150] |
Pusic, Andrea, MD, MHS |
Pilot Study of Sulindac, a Pan-COX Inhibitor, in Oral Premalignant Lesions
[Protocol 04-099] |
Boyle, Jay, MD |
Surviving Oropharynx Cancer: Long-Term Impact of Human Papillomavirus on Quality of Life
[Protocol 10-111] |
Pfister, David, MD |
